vs
波士顿科学(MLSS)与Peraso Inc.(PRSO)财务数据对比。点击上方公司名可切换其他公司
Peraso Inc.的季度营收约是波士顿科学的1.4倍($2.9M vs $2.1M),Peraso Inc.净利率更高(-43.3% vs -53.0%,领先9.7%),波士顿科学同比增速更快(2.2% vs -22.0%),过去两年Peraso Inc.的营收复合增速更高(1.0% vs -4.3%)
波士顿科学公司是源自美国的跨国生物医疗企业,专业研发生产介入医疗领域医疗器械,产品覆盖介入放射学、介入心脏病学、外周介入治疗、神经调控、神经血管介入、电生理、心脏外科、血管外科、内镜、肿瘤学、泌尿与妇科等多个领域。
Peraso Inc.是一家半导体技术企业,专注于设计和生产高性能毫米波(mmWave)集成电路与模块,为电信基础设施、工业物联网、固定无线接入及消费电子领域提供5G及下一代无线连接解决方案,服务全球多个地区的客户。
MLSS vs PRSO — 直观对比
营收规模更大
PRSO
是对方的1.4倍
$2.1M
营收增速更快
MLSS
高出24.2%
-22.0%
净利率更高
PRSO
高出9.7%
-53.0%
两年增速更快
PRSO
近两年复合增速
-4.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $2.1M | $2.9M |
| 净利润 | $-1.1M | $-1.2M |
| 毛利率 | 73.0% | 52.2% |
| 营业利润率 | -52.5% | -44.6% |
| 净利率 | -53.0% | -43.3% |
| 营收同比 | 2.2% | -22.0% |
| 净利润同比 | 46.4% | 20.3% |
| 每股收益(稀释后) | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MLSS
PRSO
| Q4 25 | $2.1M | $2.9M | ||
| Q3 25 | $2.4M | $3.2M | ||
| Q2 25 | $2.3M | $2.2M | ||
| Q1 25 | $2.2M | $3.9M | ||
| Q4 24 | $2.0M | $3.7M | ||
| Q3 24 | $2.5M | $3.8M | ||
| Q2 24 | $1.9M | $4.2M | ||
| Q1 24 | $2.2M | $2.8M |
净利润
MLSS
PRSO
| Q4 25 | $-1.1M | $-1.2M | ||
| Q3 25 | $-1.2M | $-1.2M | ||
| Q2 25 | $-1.5M | $-1.8M | ||
| Q1 25 | $-2.0M | $-471.0K | ||
| Q4 24 | $-2.0M | $-1.6M | ||
| Q3 24 | $-1.5M | $-2.7M | ||
| Q2 24 | $223.6K | $-4.4M | ||
| Q1 24 | $-1.4M | $-2.0M |
毛利率
MLSS
PRSO
| Q4 25 | 73.0% | 52.2% | ||
| Q3 25 | 69.5% | 56.2% | ||
| Q2 25 | 69.6% | 48.3% | ||
| Q1 25 | 73.8% | 69.3% | ||
| Q4 24 | 75.0% | 56.3% | ||
| Q3 24 | 73.0% | 47.0% | ||
| Q2 24 | 76.1% | 55.5% | ||
| Q1 24 | 74.5% | 46.4% |
营业利润率
MLSS
PRSO
| Q4 25 | -52.5% | -44.6% | ||
| Q3 25 | -48.1% | -36.8% | ||
| Q2 25 | -63.9% | -80.0% | ||
| Q1 25 | -89.5% | -13.3% | ||
| Q4 24 | -101.4% | -44.3% | ||
| Q3 24 | -58.4% | -70.3% | ||
| Q2 24 | -96.0% | -105.6% | ||
| Q1 24 | -65.1% | -128.9% |
净利率
MLSS
PRSO
| Q4 25 | -53.0% | -43.3% | ||
| Q3 25 | -48.9% | -37.4% | ||
| Q2 25 | -63.8% | -82.4% | ||
| Q1 25 | -89.3% | -12.2% | ||
| Q4 24 | -101.1% | -42.4% | ||
| Q3 24 | -58.1% | -70.6% | ||
| Q2 24 | 12.1% | -104.4% | ||
| Q1 24 | -64.1% | -72.1% |
每股收益(稀释后)
MLSS
PRSO
| Q4 25 | — | $-0.09 | ||
| Q3 25 | $-0.01 | $-0.17 | ||
| Q2 25 | — | $-0.31 | ||
| Q1 25 | — | $-0.10 | ||
| Q4 24 | — | $0.36 | ||
| Q3 24 | $-0.02 | $-0.98 | ||
| Q2 24 | — | $-1.88 | ||
| Q1 24 | — | $-1.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.1M | $2.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.8M | $4.6M |
| 总资产 | $7.8M | $6.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
MLSS
PRSO
| Q4 25 | $1.1M | $2.9M | ||
| Q3 25 | $1.3M | — | ||
| Q2 25 | $1.3M | — | ||
| Q1 25 | $2.2M | — | ||
| Q4 24 | $3.3M | $3.3M | ||
| Q3 24 | $4.8M | $1.3M | ||
| Q2 24 | $5.8M | $1.9M | ||
| Q1 24 | $5.0M | $2.4M |
股东权益
MLSS
PRSO
| Q4 25 | $2.8M | $4.6M | ||
| Q3 25 | $2.5M | $3.6M | ||
| Q2 25 | $3.3M | $3.0M | ||
| Q1 25 | $4.5M | $3.6M | ||
| Q4 24 | $5.8M | $3.5M | ||
| Q3 24 | $7.2M | $2.0M | ||
| Q2 24 | $8.0M | $3.6M | ||
| Q1 24 | $7.5M | $6.7M |
总资产
MLSS
PRSO
| Q4 25 | $7.8M | $6.1M | ||
| Q3 25 | $8.5M | $6.2M | ||
| Q2 25 | $8.1M | $5.5M | ||
| Q1 25 | $9.1M | $6.7M | ||
| Q4 24 | $9.8M | $7.2M | ||
| Q3 24 | $11.2M | $7.2M | ||
| Q2 24 | $12.0M | $9.8M | ||
| Q1 24 | $11.4M | $11.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-226.1K | $-1.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
MLSS
PRSO
| Q4 25 | $-226.1K | $-1.1M | ||
| Q3 25 | $81.8K | $-1.5M | ||
| Q2 25 | $-1.8M | $-2.0M | ||
| Q1 25 | $-1.0M | $-966.0K | ||
| Q4 24 | $-1.5M | $-687.0K | ||
| Q3 24 | $-973.9K | $-683.0K | ||
| Q2 24 | $783.7K | $-659.0K | ||
| Q1 24 | $-1.2M | $-2.5M |
自由现金流
MLSS
PRSO
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
MLSS
PRSO
| Q4 25 | — | — | ||
| Q3 25 | — | -48.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
MLSS
PRSO
| Q4 25 | — | — | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率
MLSS
PRSO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.50× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MLSS
暂无分部数据
PRSO
| Products | $2.8M | 96% |
| Other | $105.0K | 4% |